PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-12-09 (3)

Date Title Company
09-Dec-2022 Exelixis Provides Update on Phase 3 CONTACT-01 Trial Evaluating Cabozantinib in Combination with Atezolizumab in Patients with Metastatic Non-Small Cell Lung Cancer Previously Treated with Immunotherapy and Chemotherapy Businesswire